Bausch Health Companies (BHC) Form 3 Bausch Health Companies / Seana Carson ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Carson Seana

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
05/10/2022

3. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
EVP, General Counsel

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares, No Par Value	68,570(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Options (right to purchase)	(2)	11/11/2023	Common Shares, No Par Value	21,492	105.44	D
Non-Qualified Stock Options (right to purchase)	(2)	06/09/2026	Common Shares, No Par Value	3,996	23.92	D
Non-Qualified Stock Options (right to purchase)	(2)	02/27/2029	Common Shares, No Par Value	4,246	23.16	D
Non-Qualified Stock Options (right to purchase)	(2)	02/26/2030	Common Shares, No Par Value	18,115	24.77	D
Non-Qualified Stock Options (right to purchase)	(2)	03/03/2031	Common Shares, No Par Value	11,360	32.56	D
Non-Qualified Stock Options (right to purchase)	(2)	03/03/2032	Common Shares, No Par Value	124,372	24.17	D

Explanation of Responses:

1. Includes 50,510 restricted share units ("RSUs") which vest in equal installments on each of the first three anniversaries following the date of grant. Vested RSUs are settled in Common Shares, no par value, of the Issuer.

2. Vests in equal installments on each of the first three anniversaries of the date of grant.

	/s/ Brianna M. Cetrulo, attorney-in-fact for Seana Carson	05/12/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.